MGX Minerals Mobilizes for 100 Tonne Bulk Sample at Driftwood Creek Magnesium Project

Press Releases |

VANCOUVER, BRITISH COLUMBIA / November 19, 2015 / MGX Minerals Inc. (“MGX” or the “Company”) ($XMG:CNX) (FKT: 1MG) is pleased to report that mobilization is underway for the mining of a 100 tonne bulk sample at its flagship Driftwood Creek magnesium project (“Driftwood Creek”). The previously announced bulk sample program (see press release dated November 4, 2015) is expected to commence shortly. Equipment and field crews are scheduled to arrive on site at Driftwood Creek over the next few days, with commencement of the bulk sample program scheduled to begin next week, weather dependent.

The bulk sample is scheduled for transportation to the Industrial Furnace Company (“IFCO”) in Rochester, New York for pilot plant testing. Results of pilot plant testing will determine final specifications to optimize the design and construction parameters of industrial-sized kilns to process magnesite from Driftwood Creek. MGX plans to make multi-tonne samples of caustic calcined magnesia (CCM) and dead-burned magnesia (DBM) available for sale to customers.

About MGX Minerals

MGX Minerals (CSE: XMG) is a diversified Canadian mining company listed on the Canadian Securities Exchange. MGX is engaged in the acquisition and development of industrial mineral deposits in western Canada that offer near-term production potential, minimal barriers to entry and low initial capital expenditures.

The Company’s flagship project is the Driftwood Creek magnesium project in the East Kootenay region of British Columbia. The long-term strategic business objectives of the Company include constructing a quarry mine and processing plant to produce magnesium oxide from Driftwood Creek. The Driftwood Creek project is currently under permitting review for granting of a mining lease and applications for associated operating permits are in various stages of preparation. MGX owns the majority of significant magnesite properties in the Province of British Columbia as reported by the British Columbia Geological Service (British Columbia Mineral Titles Branch).

For more information please visit the Company’s website at www.mgxminerals.com.

Contact Information

 

Jared Lazerson
Chief Executive Officer
Telephone: 604.681.7735
Email: jared@mgxminerals.com

Dr. Michael Reimann
Chief Financial Officer
Telephone: 604.681.7735
Email: michael@mgxminerals.com


Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release.

Forward-Looking Statements

This press release contains forward-looking information or forward-looking statements (collectively "forward-looking information") within the meaning of applicable securities laws. Forward-looking information is typically identified by words such as: "believe", "expect", "anticipate", "intend", "estimate", "potentially" and similar expressions, or are those, which, by their nature, refer to future events. The Company cautions investors that any forward-looking information provided by the Company is not a guarantee of future results or performance, and that actual results may differ materially from those in forward-looking information as a result of various factors. The reader is referred to the Company's public filings for a more complete discussion of such risk factors and their potential effects which may be accessed through the Company's profile on SEDAR at www.sedar.com.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Veritas Pharma Inc.

Veritas Pharma Inc, formerly Seashore Organic Medicine Inc is an emerging producer and distributor of medical marijuana.

Private Markets

Lyft

Lyft matches drivers using their own personal vehicles with passengers who request rides through the smartphone app, and the passengers pay automatically through the app. When using Lyft, passengers have…

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…